CPHI vs XRAY · rev $4.1M vs rev $3.68B
China Pharma Holdings Inc (CPHI) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported XRAY revenue for 2025-12-31 was $3.68B. Net income was -$598.0M. Revenue was down 3.0% from 2024-12-31 to 2025-12-31. XRAY currently screens at market cap $2.01B.
CPHI currently screens at market cap $29.0M. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the CPHI and XRAY stock pages for the full models.
Not investment advice.